Are We at a Tipping Point for Health Products Manufacturing in Africa? Exploring the Implications of PEPFAR’s Regional Production Goal
Date: Tuesday, April 11, 2023
Time: 8:00 am – 9:30 am EST
Location: Virtual via Zoom
At the US-Africa Leaders’ Summit in December 2022 and as part of the newly issued PEPFAR five-year strategy, Ambassador Dr. John Nkengasong, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy announced bold goals to procure 15 million HIV tests from African manufacturers by 2025 and procure first-line antiretrovirals for at least two million clients from manufacturers on the continent by 2030. To reach these goals, PEFPAR is planning to review procurement policies, regulatory pathways, and potential financing mechanisms to incentivize the sustainable scale-up of the pharmaceutical manufacturing sector in Africa.
This announcement underscores the US Government’s commitment to ensuring equitable access to critical HIV products and marks a critical and concrete commitment from one of the world’s largest procurers of health commodities. PEPFAR’s commitment may well serve as a catalyst for additional commitments from other donors and multilateral organizations. During this event, we will discuss whether PEPFAR’s move may have the potential to serve as a tipping point for creating long-term sustainable support for African manufacturing of quality-assured health products.
Join the Corporate Council on Africa, the Office of the U.S. Global AIDS Coordinator and Health Diplomacy (OGAC), and U.S. Pharmacopeia for this virtual event that will feature opening remarks from Ambassador Dr. John Nkengasong, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy along with a distinguished panel to explore how PEPFAR’s goal may be a tipping point for fostering more robust health products manufacturing capacity on the African continent.
The virtual event will explore policy, financing, and regulatory measures needed to support PEPFAR in meeting its goals and explore how commitments like these can pave the way for long-term sustainable health products manufacturing on the African continent. This discussion will pull in diverse perspectives from government and the private sector to examine where opportunity exists and what challenges must be addressed to create an enabling environment for the production of rapid diagnostics and first-line ARVs in Africa and will help inform PEPFAR’s forthcoming roadmap for achieving its regional production goals.
This webinar is presented by CCA’s U.S.-Africa Health Security and Resilience Initiative (HSRI). HSRI brings together major U.S. and African leaders, corporations, multilateral organizations, foundations, and other health sector stakeholders to collaborate on developing policies, promoting strategic partnerships, providing critical Africa health-related information, and facilitating investment to strengthen Africa’s health systems security and resilience